Evommune (EVMN) Interest Expenses (2024 - 2026)

Evommune (EVMN) reported Interest Expenses of $4000.0 for Q1 2026, down 69.23% year-over-year from $13000.0 in Q1 2025, and down 55.56% quarter-over-quarter from $9000.0 in Q3 2025.

Evommune (EVMN) Interest Expenses (2024 - 2026) Analysis & Trends

Evommune (EVMN) has 3 years of Interest Expenses data on file, last reported at $4000.0 in Q1 2026.

  • Interest Expenses for Q1 2026 came in at $4000.0, down 69.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $26000.0 (changed N/A YoY), and the FY2025 annual result was $50000.0, up 35.14% from the prior year.
  • Interest Expenses slipped to $4000.0 in Q1 2026 per EVMN's latest filing, from $9000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $17000.0 in Q3 2024 and troughed at -$1000.0 in Q4 2024.
  • A 3-year average of $8400.0 and a median of $9000.0 in 2025 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2025 and 2026: Interest Expenses sank 47.06% in 2025, then sank 69.23% in 2026.
  • A 3-year view of Interest Expenses shows it stood at -$1000.0 in 2024, then soared by 1000.0% to $9000.0 in 2025, then sank by 55.56% to $4000.0 in 2026.
  • Business Quant data shows EVMN's Interest Expenses at $4000.0 in Q1 2026, $9000.0 in Q3 2025, and $13000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Evommune 695.29 Mn 483.82 Mn - 4,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Mar 31, 2026 4,000.00
Sep 30, 2025 9,000.00
Sep 30, 2025 9,000.00
Mar 31, 2025 13,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 -1,000.00
Dec 31, 2024 -1,000.00
Sep 30, 2024 17,000.00
Sep 30, 2024 17,000.00